To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 25,566 shares, the number of shares held increased 4.24% compared to the previous period and now represents 1.07% of the total position.
      72Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 189,152 shares, the number of shares held increased 4.16% compared to the previous period and now represents 2.4% of the total position.
      4Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in Illumina by 15,200 shares, the number of shares held increased 4.16% compared to the previous period and now represents 4.27% of the total position.
      25Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 80,992 shares, the number of shares held increased 4.16% compared to the previous period and now represents 2.07% of the total position.
      128Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in Natera by 10,144 shares, the number of shares held increased 4.15% compared to the previous period and now represents 4.2% of the total position.
      67Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 822,247 shares, the number of shares held increased 6.89% compared to the previous period and now represents 2.69% of the total position.
      5.35K4
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 19,168 shares, the number of shares held increased 4.16% compared to the previous period and now represents 4.34% of the total position.
      78Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in Eli Lilly by 2,262 shares, the number of shares held increased 6.08% compared to the previous period and now represents 2.82% of the total position.
      23Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 17,696 shares, the number of shares held increased 4.15% compared to the previous period and now represents 1.93% of the total position.
      159Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-28 07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 11,136 shares, the number of shares held increased 4.15% compared to the previous period and now represents 1.38% of the total position.
      194Comment
      Report
       
       
       
       

      Most Discussed